Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
BMC Medical Imaging|August 10, 2021
A vein-viewing application enabled detecting abdominal wall varices related to the presence of non-treated gastroesophageal varices: a cross-sectional studyYoshiki Hoshino, Takaaki Sugihara, Suguru Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 31, 2002
A case with hepatic fibrosis showing ascites and esophageal varices induced by oral UFT(R) administrationTakeaki Suou, Kiwamu Tanaka, Jun ichi Okano, et al.
Yonago Acta Medica|April 6, 2016
Preventive Effect of Geraniol on Diethylnitrosamine-Induced Hepatocarcinogenesis in RatsShintaro Sawada, Jun-Ichi Okano, Ryu Imamoto, et al.
Biochemical and Biophysical Research Communications|September 3, 2003
Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathwayJun-ichi Okano, Goshi Shiota, Kazuya Matsumoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 12, 2022
[Small duct primary sclerosing cholangitis diagnosed after fever and liver disorder: a case report]Takuya Kihara, Takaaki Sugihara, Suguru Ikeda, et al.
DEN Open|March 25, 2025
Gastric inverted polyp successfully resected by underwater endoscopic mucosal resectionYuki Nakamura, Takahiro Nomi, Sho Yasui, et al.
Yonago Acta Medica|March 24, 2017
Serum Procalcitonin in Patients with Acute Liver FailureTakaaki Sugihara, Masahiko Koda, Toshiaki Okamoto, et al.
Yonago Acta Medica|November 30, 2020
Erratum for Ikeda et al., "Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease"Suguru Ikeda, Takaaki Sugihara, Yoshiki Hoshino, et al.
Yonago Acta Medica|March 24, 2017
Falsely Elevated Serum Vitamin B<sub>12</sub> Levels Were Associated with the Severity and Prognosis of Chronic Viral Liver DiseaseTakaaki Sugihara, Masahiko Koda, Toshiaki Okamoto, et al.
Yonago Acta Medica|September 5, 2020
Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver DiseaseSuguru Ikeda, Takaaki Sugihara, Yoshiki Hoshino, et al.
Pageof 4